Speakers

Prof. Oliver Dorigo

keynote Talk: Tumor associated Macrophages in Ovarian Cancer

Director, Division Gynecologic Oncology and

Director, Stanford Gynecologic Oncology Clinical Care Program

Stanford University, Stanford, US

Prof. Disis, Mary L. (Nora)

Vaccines for breast cancer prevention

Fred Hutchinson Cancer Research Center, Seattle, WA, USA

Prof. Pawel Kalinski

Dendritic Cells: Cancer Vaccines , Modulators of TME and Inducers of T-cells for Adoptive T-cell Therapy

Jacobs Family Endowed Chair in Immunology, Roswell Park Comprehensive Cancer Center, Buffalo NY, USA

Dr Luisa M. Solis

Immune Programs Associated to Tumoral Tertiary Lymphoid Structures at Different Maturation Stages in Early-stage Lung Adenocarcinoma

Director of the Immunohistochemistry and Digital Pathology Laboratory & Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, TX, USA

Prof. Zuo-Feng Zhang

Covid-19 and Noncommunicable diseases Prevention and control

Fielding School of Public Health, University of California, Los Angeles, USA.

Dr Shilpa Gupta

Defining platinum-ineligibility: I know it when I see it?

Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, USA

Prof. George Hajishengallis

Translating C3 inhibition in periodontal inflammation

University of Pennsylvania, Penn Dental Medicine, Philadelphia, Pennsylvania, USA.

Prof. Guru Sonpavde

A practical approach to selection of first-line treatment for metastatic urothelial cancer

Dana Farber Cancer Institute, Harvard Medical School, Boston, USA

Prof. Cecilia Lindestam Arlehamn

T cell immune signatures triggered by Mycobacteria

La Jolla Immunology Institute, San Diego, California USA

151941479-0cd99047-15ca-47b0-89a2-49f3e474009c

Prof. Paolo Marchetti

Immunobiology personalized approaches in oncology

Istituto di Ricovero e Cura a Carattere Scientifico (IDI-IRCCS), Rome, Italy

Prof. Matthew Galsky

Defining an ‘unfilt’ patient for Cisplatin-based chemo for the upfront treatment of metastatic urothelial carcinomas

Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, NY, USA

Prof. Cara Haymaker

Multiomics approaches to define actionable targets in malignant pleural mesothelioma

UT MD Anderson Cancer Center, Houston, TX, US

Prof. Che-Kai Tsao

Understanding the Genomic Landscape of Advaced Prostate Cancer

Medical Director, Ruttenberg Treatment Center, Tisch Cancer Institute, Mount Sinai Hospital, NY, USA.

Prof. Agrati Chiara

Myeloid derived Suppressor cells: key players in shaping the delicate balance between inflammation and immune-suppression in COVID-19 patients

National Institute for Infectious Diseases-IRCCS L. Spallanzani, Rome, Italy

Prof. Scott T. Tagawa

Improving outcomes for patients with non-castrate (castration-sensitive) prostate cancer

Medical Director, Genitourinary Oncology Research Program, Weill Cornell Medical College, New York, USA

Prof. Delia Goletti

Whole blood tests to measure T cell specific response in infectious diseases

National Institute for Infectious Diseases-IRCCS L. Spallanzani, Rome, Italy

Prof. Antonio Maria Risitano

Complement therapeutics in hematological disorders: lessons from PNH

AORN Moscati Avellino, Italy and Federico II University of Naples, Naples, Italy

Prof. Simone Joosten

Mycobacterial growth control in natural vs vaccine induced protection

Leiden University Medical Center, Leiden, The Netherlands

Prof. Hongtao Zhang

Development of targeted immunotherapy for HER2 tumors

Department of Pathology, Perelman School of Medicine, Philadelphia, USA.

Dr Linda Petrone

Immune diagnostic tests for Echinococcosis

National Institute for Infectious Diseases-IRCCS L. Spallanzani, Rome, Italy

Dr Jennifer N. Dines

Network-Based Omics Approach Enables Precision Medicine Diagnostics and Drug Development

Scipher Medicine Corp, Waltham, MA

Prof. Neeraj Agarwal

Treatment of Metastatic Castration Sensitive Prostate Cancer

Chair of Cancer Research at the Huntsman Cancer Institute (HCI), University of Utah, Salt Lake City, UT, USA

Prof. Giovanni Delogu

Host directed therapies against mycobacterial infections

Università Cattolica del Sacro Cuore, Rome, Italy

Prof. Panagiotis Skendros

Targeting complement: from benchside to bedside | Round Table Discussion

Democritus University of Thrace (DUTH), University Hospital of Alexandroupolis, Greece

Prof. Jyothi Rengarajan

Deep Spatial Profiling of the Tuberculosis Lung

Emory Vaccine Center Emory National Primate Center, Emory University, Atlanta, GA, USA

Dr Dimitrios C. Mastellos

Complement Immunobiology

National Center for Scientific Research ‘Demokritos’, Athens, Greece

Dr Cristina M. Failla

Coupling vitiligo development and therapeutic efficacy: a new challenge for immunotherapy in cutaneous melanoma

Experimental Immunology Laboratory, IDI-IRCCS, Rome, Italy

7D52DEA1B2188DFA869B0FD7A4E_E8C37BA6_11388

Dr Bin Li

FOXP3 Instability and Treg cell-based therapy

Shanghai Institute of Immunology, SHSMU, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Prof. Viviana Izzo

Engineering Bacterial Outer Membrane Vesicles for novel Immunotherapeutics

Department of Medicine, Surgery and Dentistry, Università degli Studi Salerno, Baronissi (SA), Italy

Dr Tibor Bakács

Severe Herpes Zoster Ophthalmicus: An Autobiographical Case Report

Hungarian Academy of Sciences & HepC Inc, Hungary

Prof. Chulho Oak

Future aspect of smart remote health monitoring in the midst of pandemic such as Covid

Kosin University College of Medicine, Pusan, South Korea

Dr Francesca Scatozza

Expression of autoimmunity-related genes in melanoma

Istituto di Ricovero e Cura a Carattere Scientifico (IDI-IRCCS), Rome, Italy

Prof. John B. Liao

Strategies to develop effective immune therapy for ovarian cancer

University of Washington Medical Center, Washington, USA

Dr Marco de Feo

Arenavirus and odontogenic fibrous bone tumours: food-borne pathogens, eating habits and novel hypothesis

Saint Mary’s Hospital Lacor, Gulu, Uganda

Dr Tonino Alonzi

Cysteamine: a new therapy for SARS-CoV-2?

National Institute for Infectious Diseases-IRCCS L. Spallanzani, Rome, Italy

Prof. Yangxin Fu

Bispecific fusion proteins: targeting tumor cells or immune cells

Basic medical science, Tsinghua University, Beijing, China

Dr Edgar Gonzalez-Kozlova

Extracellular vesicle RNAs as diagnostics and future therapeutics in cancer

Department of Oncological Sciences, Icahn School of Medicine, New York, NY, USA

★ Agenda is being updated regularly